Literature DB >> 1148664

Co-trimoxazole in chronic brucellosis: a two-year follow-up study.

P A Kontoyannis, S E Papapoulos, A A Mortoglou.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1148664      PMCID: PMC1673381          DOI: 10.1136/bmj.2.5969.480-a

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


× No keyword cloud information.
  3 in total

1.  Trimethoprim-sulfamethoxazole in brucellosis.

Authors:  G K Daikos; N Papapolyzos; N Marketos; S Mochlas; S Kastanakis; E Papasteriadis
Journal:  J Infect Dis       Date:  1973-11       Impact factor: 5.226

2.  Trimethoprim-sulfamethoxazole combination in the treatment of acute human brucellosis.

Authors:  G Giunchi; F De Rosa; F Fabiani
Journal:  Chemotherapy       Date:  1971       Impact factor: 2.544

3.  Acute brucellosis treated with trimethoprim and sulphamethoxazole.

Authors:  S Lal; K K Modawal; A S Fowle; B Peach; R D Popham
Journal:  Br Med J       Date:  1970-08-01
  3 in total
  3 in total

1.  Brucellosis: difficulties in diagnosis and a report on 38 cases.

Authors:  Y Samra; Y Shaked; M Hertz; G Altman
Journal:  Infection       Date:  1983 Nov-Dec       Impact factor: 3.553

2.  Brucellar arthritis in children and its successful treatment with trimethoprim-sulphamethoxazole (co-trimoxazole).

Authors:  F J Gómez-Reino; I Mateo; A Fuertes; J J Gómez-Reino
Journal:  Ann Rheum Dis       Date:  1986-03       Impact factor: 19.103

Review 3.  Co-trimoxazole (trimethoprim-sulfamethoxazole): an updated review of its antibacterial activity and clinical efficacy.

Authors:  G P Wormser; G T Keusch; R C Heel
Journal:  Drugs       Date:  1982-12       Impact factor: 9.546

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.